Reuters logo
BRIEF-Uniqure Q4 loss per share $0.58
March 15, 2017 / 1:29 PM / 6 months ago

BRIEF-Uniqure Q4 loss per share $0.58

March 15 (Reuters) - Uniqure Nv

* Uniqure announces 2016 financial results and provides update on company progress

* Q4 loss per share $0.58

* Uniqure nv- as of december 31, 2016, company held cash and cash equivalents of $132.5 million, compared with $221.6 million as of december 31, 2015

* Uniqure nv- company expects its cash on hand will be sufficient to fund operations into 2019

* Uniqure nv says plans to advance hemophilia b program into late-stage clinical development are ongoing, with a pivotal trial expected to begin in 2018

* Uniqure nv says continues to advance amt-130 towards filing an investigational new drug (ind) application to begin clinical studies in 2018

* Uniqure nv -intends to reduce capital expenditures in 2017 and 2018 and realize operational cost savings from strategic restructuring initiated in nov 2016 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below